Scholars Central

LetterPublished 29 Aug 2021

Role of Mesenchymal stem cells in the treatment of COVID-19 infected patients

Authors: Vinay Kumar Mehra

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The first case of COVID-19 was detected in Wuhan, China, in December 2019 after within few days the number of COVID-19 patients have rapidly increased not only in China, but also worldwide, including Germany, , Italy, and USA, India and other counties and become epidemic. COVID-19 is a positive-stranded RNA virus having spike glycoproteins on their surface which cause respiratory disease. Currently there is no drug or vaccine is available to treat this disease worldwide. So in this report I suggest a new approach to improve patient's health to COVID-19 using mesenchymal stem cells. MESENCHYMAL STEM CELLS: Mesenchymal stem cells are multipotent stem cells which have the capability to differentiate into a variety of cell types, including bone cells, cartilage cells, muscle cell) and fat cells. MSCs have immunomodulatory properties including cytokines, immune-receptors and secretion of anti-inflammatory molecules which makes MSCs an effective tool for treatment of many chronic diseases. They are present not only in fetal tissues but also in many adult tissues.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in BioTechnology: An Indian Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBioTechnology: An Indian Journal
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Vinay Kumar Mehra”